Independent in relation to the Company and its management: No
Independent in relation to major shareholders: Yes
Holdings in Alligator: 42,775 shares, 500,000 warrants in program TO 2022/2025 I, 1,200,000 warrants in program TO 2023/2026 I, 900,000 warrants in program TO 2024/2027 I, 41,649,000 warrants TO 12 and 20,744,500 warrants TO 13.
Other current positions: Chairman of A Bioscience Incentive AB and Atlas Therapeutics AB, and Board member of Oblique Therapeutics AB (publ).
We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our
cookie policy.
